Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.01.2021 | Case report

Lenvatinib/ramucirumab

Hand-foot syndrome and exacerbation of psoriasis: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Hayakawa Y, et al. A case of unresectable hepatocellular carcinoma maintaining stable disease by using anti-vascular endothelial growth factor receptor antibody after the exacerbation of psoriasis due to small-molecule kinase inhibition. Kanzo 61: 513-519, No. 10, 2020. Available from: URL: http://doi.org/10.2957/kanzo.61.513 [Japanese; summarised from a translation] Hayakawa Y, et al. A case of unresectable hepatocellular carcinoma maintaining stable disease by using anti-vascular endothelial growth factor receptor antibody after the exacerbation of psoriasis due to small-molecule kinase inhibition. Kanzo 61: 513-519, No. 10, 2020. Available from: URL: http://​doi.​org/​10.​2957/​kanzo.​61.​513 [Japanese; summarised from a translation]
Metadaten
Titel
Lenvatinib/ramucirumab
Hand-foot syndrome and exacerbation of psoriasis: case report
Publikationsdatum
01.01.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-88279-7

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe